...
🎄Holiday Notice: Shipping for temperature-sensitive medications (Ozempic, Mounjaro, etc.) is paused. Service resumes Monday, Dec 29.

Generic Semaglutide: Lower-Cost Semaglutide is Here!

BUY NOW

Us Flag

We Ship To The U.S. Only

Generic Semaglutide: Lower-Cost Semaglutide is Here!

Us Flag

We Ship To The U.S. Only

SAVE 10% OFF First Order With Coupon Code:WELCOME10

Generic Semaglutide (Generic Ozempic) Dosage Chart

Medically Reviewed By

(Pharm D), MBA, M.Phil and MSPH

Buy Semaglutide From Canada
Ozempic Logo Custom

10% Off On Your First Order

Click on the Copy Code button to copy your code.

No Expiry

Copy Code
DFM10
10%
OFF
10%
OFF

Exclusive On Duty Free Meds Only

Buy Semaglutide From Canada
Ozempic Logo Custom

10% Off On Your First Order

Click on the Copy Code button to copy your code.

No Expiry

Copy Code
DFM10
10%
OFF
10%
OFF

Exclusive On Duty Free Meds Only

What Is The Usual Generic Semaglutide Dose?

Generic semaglutide injections are usually prescribed at an initiation dose (non-therapeutic dose) of 0.25 mg once per week. The dose of this medication is usually increased to 0.5 mg each week after four weeks of being on the 0.25 mg dose. A doctor may then increase the patient’s dose to 1 mg per week if additional control is needed after at least four more weeks have passed. The maximum recommended dose for this specific Ozempic-equivalent product is 2 mg once weekly after the patient has been on the 1 mg dose for at least four weeks; other semaglutide formulations have different approved maximum doses. The current Dr. Reddy’s Laboratories and Apotex Canada-authorized generics are Ozempic-equivalent medications that are indicated for type 2 diabetes. This means that this medication’s dosing is not intended or approved for the purpose of weight loss. Patients should use only the dose prescribed for their exact product.

This chart is general product-label information, not a personalized dosing plan. Do not increase, decrease, or restart semaglutide without instructions from a licensed healthcare provider.

Generic Semaglutide (Generic Ozempic) Dosage Chart

Generic Semaglutide Dosage Chart
Generic Semaglutide Dosage Chart V3 Mobile

Generic semaglutide weekly dosage chart for type 2 diabetes

Treatment stageTime on treatmentTypical weekly doseNotes
Starting doseWeeks 1-40.25 mg once weeklyHelps the body adjust. The Canadian product monograph states that this is a starting dose used for treatment initiation and gastrointestinal tolerability; it is not intended as a maintenance therapeutic dose.
Dose increaseWeeks 5-80.5 mg once weeklyThe dose may be increased to 0.5 mg once weekly after at least 4 weeks at 0.25 mg.
Further increaseWeek 9+1 mg once weeklyThe dose may be increased to 1 mg once weekly after at least 4 weeks at 0.5 mg if additional glycemic control is needed.
Maximum doseAfter at least 4 weeks at 1 mg2 mg once weeklyThe dose may be increased to 2 mg once weekly if additional glycemic control is needed. This is the maximum recommended weekly dose for this medication.

The chart above applies to the once-weekly semaglutide injection – not oral semaglutide. Doses are shown in milligrams and not syringe units. The highest dose will not be necessary for every patient to use and this dose should not be used to increase weight loss effects. Dose changes should only take place after the required periods if a doctor directs a patient to do so. The supplied manufacturer’s monograph and prescription instructions take priority over any general online chart.

Is There a Generic Semaglutide Dosage Chart for Weight Loss?

There is no separate dosing schedule specifically established for generic semaglutide for weight loss. However, Sevmia – a generic version of Wegovy – was officially authorized in Canada on June 29, 2026. This medication currently only comes in the form of 1 mg pens. The chart above applies to equivalents to Ozempic and is indicated for type 2 diabetes. Wegovy is the semaglutide product with an approved injectable weight-management dosing schedule. The first generic semaglutide products were generic versions of Ozempic for once-weekly treatment of adults with type 2 diabetes.

Why Generic Semaglutide is Associated With Weight Loss

Generic semaglutide often does cause patients to lose weight since it lowers patients’ appetite and makes them feel full faster. This often causes patients to consume less food. However, generic semaglutide is a diabetes product. Wegovy also contains semaglutide but is labeled for weight management in qualifying patients. A doctor may also prescribe a medication outside its authorized indication. This does not mean that the medication has officially approved generic weight-loss doses.

Semaglutide Dosage Chart for Weight Loss

Approved name-brand Wegovy already exists for weight loss. The chart below explains the approved dosing for this medication. Patients should note that this is different than the diabetes-labeled product – which does not have an approved weight-loss dosing schedule.

Treatment stageWeeksWegovy injection doseNotes
Starting dose1-40.25 mg once weeklyInitiation dose. This is a starting dose used for treatment initiation and gastrointestinal tolerability; it is not intended as a maintenance therapeutic dose.
Escalation dose5-80.5 mg once weeklyContinue escalation if tolerated.
Escalation dose9-121 mg once weeklyContinue escalation if tolerated.
Maintenance dose13-16+1.7 mg once weeklyContinue escalation if tolerated. This dose may be the prescribed maintenance dose for some patients.
Further increase17-20+2.4 mg once weeklyContinue escalation if tolerated. This dose may be the prescribed maintenance dose for some patients if additional weight reduction is needed.
Maximum dose21+7.2 mg once weeklyMaximum labeled injectable dose. This dose was officially approved on March 19, 2026, and is called Wegovy HD.

The current Wegovy label uses the 0.25, 0.5, 1 and 1.7 mg escalation stages. The maintenance dose for adults is usually 1.7 or 2.4 mg weekly. A clinician may increase the dose to a maximum of 7.2 mg (Wegovy HD) when further weight reduction is clinically indicated after patients have been on the 2.4 mg dose for at least four weeks. Dose escalation is not automatic and may be delayed based on nausea, vomiting, glycemic response, tolerability, renal status, or clinician judgment.

Disclaimer: This is the current Wegovy injection schedule. It is included to explain approved semaglutide dosing for weight management and should not be used to adjust a generic Ozempic-equivalent product.

Generic semaglutide vs. Ozempic vs. Wegovy dosing

Warning: The medications in the table below are not interchangeable medications despite containing the same active ingredient.

ProductPrimary authorized use discussed hereTypical escalationUsual or maximum labeled dose
Canada-authorized generic semaglutide equivalent to OzempicType 2 diabetes0.25 → 0.5 → 1 → 2 mgMaximum 2 mg weekly
OzempicType 2 diabetes and other label-specific risk-reduction indications0.25 → 0.5 → 1 → 2 mgMaximum 2 mg weekly
WegovyWeight reduction and other label-specific indications0.25 → 0.5 → 1 → 1.7 → 2.4 mgSelected adults may use up to 7.2 mg

The Ozempic label has all patients start with a starting dose of 0.25 mg once weekly. This dose is used for treatment initiation and gastrointestinal tolerability – which is not intended as a maintenance therapeutic dose – for the first four weeks of treatment before this dose is increased to 0.5 mg per week. Some patients may be kept on this maintenance dose. Others may be prescribed 1 mg or 2 mg weekly maintenance doses instead (based on their response). The Wegovy schedule continues through 1.7 mg and 2.4 mg. 7.2 mg maintenance doses of this medication are also permitted for selected adults. Not all semaglutide products are interchangeable and generic Ozempic is not the same as generic Wegovy.

Why Are Semaglutide Doses Increased Gradually?

Semaglutide is usually started at a low dose that is used non-therapeutically to get the patient’s body adjusted to the medication and reduce gastrointestinal adverse effects. The gradual escalation schedule – with four weeks between each dose increase – is also designed to help the body adjust. Gradual escalation is intended to reduce gastrointestinal adverse reactions and moving more quickly does not necessarily produce safer or better results. The exact schedule may still vary between patients. Dose progression is based on response and tolerability – not just the amount of time that has passed. A doctor may delay an increase when a dose is not well tolerated. The Wegovy label specifically states that dose escalation is used to reduce gastrointestinal adverse reactions and permits delaying an escalation by four weeks in the case that a dose is not tolerated.

The calendar does not automatically determine the patient’s next dose. A reader who has reached week five should not assume they must increase the dose if their prescriber has advised otherwise.

How Does a Healthcare Provider Choose The Right Semaglutide Dose?

There are several factors that impact the individual doses prescribed by a doctor. These factors include those such as the exact medication being prescribed and the manufacturer that makes it. There may also be dose variations depending on the approved or intended treatment purposes. Doses may vary based on the current doses the patient is taking and the time they have spent taking those doses.

Dosing is also heavily dependent on the patient’s response to the medication. This may include the patient’s response to blood sugar control or weight management (depending on the exact use of the medication). Patients may also need dosing adjustments if they are experiencing gastrointestinal side effects or if they are taking other medications that can impact the effectiveness of semaglutide – such as insulin or sulfonylureas.

A healthcare provider may also need to make dosing adjustments for the patient if they have any kidney or liver conditions. Pregnancy plans can also impact treatment schedules since this medication is not approved for safe use during pregnancy (patients may be told to stop using this medication months ahead of time). A history of missed doses or treatment interruption may also impact the dosing schedule prescribed to give the body time to gradually readjust. Another factor that may impact the prescribed dosing of the medication is the patient’s ability to tolerate food and fluids.

What Should You Do if You Have Trouble Tolerating a Higher Dose?

Patients who have difficulty tolerating a dose increase may have their scheduled increase delayed past the typical four weeks. This means the doctor may have the patient stay on their current dose for a longer period of time to give the body time to adjust. The dose may instead be reduced in some cases. A doctor may also determine the treatment needs to be paused or discontinued in some more extreme cases. Patients should never split, improvise or estimate doses. Medical advice is required for any symptoms that are serious or persistent.

Common symptoms

Some of the side effects that are most frequently experienced by patients taking generic semaglutide are:

  • Nausea and/or vomiting
  • Diarrhea and/or constipation
  • Abdominal discomfort
  • Reduced appetite

Most gastrointestinal side effects are mild and may improve over time. However, any persistent or severe symptoms are not normal and should be reported to a healthcare professional right away. These side effects should not be taken as a sign that the medication is “working.” Patients should seek immediate medical attention for persistent or severe abdominal pain – especially if it is accompanied by vomiting or pain that radiates to the back – as these may be symptoms of pancreatitis. The same should be done for any signs of dehydration such as very little or dark urine, dizziness, or inability to keep fluids down. Immediate medical attention is also required for severe allergic reactions. These reactions may be indicated by effects such as swelling of the face, lips, or tongue. It may also be indicated by swelling of the throat, difficulty breathing, or widespread hives.

What Should You Do After Missing a Generic Semaglutide Injection?

The Canadian Apo-Semaglutide product monograph and the Canadian product monograph for Dr. Reddy’s Laboratories’ generic semaglutide both instruct patients to administer missed doses as quickly as possible within five days of when the missed dose was initially scheduled to be taken. Patients should then resume their regular dosing schedule on their normal weekly dosing day. Patients who have missed their dose for longer than five days should skip their missed dose. The rest of their dosing schedule should be followed as normal without taking any extra to make up for the missed dose. Repeatedly missing doses may require re-titration to reduce gastrointestinal intolerance rather than simply resuming the previous dose. Patients should note that other products may use differently worded missed-dose instructions. They should always follow their own product label and prescription rather than assuming every brand or formulation follows the same rule.

What happens if several semaglutide doses have been missed?

Healthcare provider guidance should be sought if multiple doses are missed. Repeated missed doses may increase the likelihood of the patient developing adverse effects. Restart schedules vary between patients and should be directly determined by the doctor.

How to Take Generic Semaglutide Once-Weekly

Generic injectable semaglutide is designed to be taken once per week. These injections should be made on the same day each week where possible. However, the injections may be made at any time on those days. These injections can also be taken with or without meals. Injections of this medication may be made into the patient’s thigh, abdomen, or upper arm. Injection sites should be rotated each week to avoid irritation. Pens or needles should never be shared between patients – even if the needle has been changed. This information is based off of the Canadian Apo-Semaglutide product monograph and the Canadian product monograph for Dr. Reddy’s Laboratories’ generic semaglutide. These monographs permit changing the weekly administration day when more than 48 hours separate the two doses. Patients should still follow the instructions supplied with the exact pen.

Safety note: Do not administer the medication intravenously or intramuscularly. Injection sites should be rotated each week to avoid irritation.

Can I change the day of my weekly semaglutide dose?

Injection days may be changed as long as at least 48 hours have passed between doses. However, patients should confirm with their prescriber or pharmacist before making this change.

When Should You Seek Professional Medical Advice About Semaglutide?

Patients should seek quick professional medical attention if they start to experience symptoms such as:

  • Severe or persistent vomiting or diarrhea
  • Signs of dehydration or inability to keep fluids down
  • Severe or persistent abdominal pain
  • Symptoms of a serious allergic reaction
  • New or worsening vision changes
  • Symptoms of very low blood sugar (particularly when semaglutide is used with insulin or certain diabetes medicines)
  • A neck lump, persistent hoarseness, and/or difficulty swallowing or breathing
  • Any suspected overdose

Can You Increase Semaglutide Early if You Are Not Losing Weight?

No. Doses of this medication should never be changed without instruction to do so from the healthcare provider. The early doses are designed for treatment initiation. The weight loss effects of the medication may differ between patients. Increasing doses of this medication too early to make the weight loss effects stronger can raise the risk of side effects. A stalled week does not by itself justify a dose change. Weight loss while taking this medication may also be impacted by the patient’s nutrition and physical activity of the patient. Health conditions and adherence also affect weight trends. The patient’s doctor should determine whether escalation is suitable.

Does a Higher Semaglutide Dose Cause More Weight Loss?

Higher doses of semaglutide may lead to different weight-loss responses among patients. These higher doses are not necessarily better or appropriate in every case. Side effects and individual response should also be considered. Patients should also keep in mind that the dose used in a clinical study does not automatically apply to a different product. The patient’s treatment objective is not necessarily to reach the maximum dose.

How Long Are Patients Supposed to Stay on Each Semaglutide Dose?

Product-label escalation stages commonly last at least four weeks. However, some patients may be kept on these for longer periods of time based on their response to the medication.

There is no universal end date to maintenance treatments. The treatment schedule may change for reasons such as tolerability, patient response, or a treatment interruption. The individual duration can only be determined by the patient’s individual prescriber.

Who Should Not Use Semaglutide?

Semaglutide is not suitable for all patients. Some of the patients this medication may not be suitable for include those with:

  • A personal or family history of medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia syndrome type 2
  • Serious hypersensitivity to semaglutide or product ingredients
  • Pregnancy or those who are breastfeeding (considerations according to the exact product label)
  • Active prescriptions for another GLP-1 medication (unless specifically directed otherwise)

Patients should make sure to disclose their complete medical history and medication list to the prescriber.

FAQs

What dose are patients started on if they are prescribed generic semaglutide?

The usual starting dose is 0.25 mg once weekly for four weeks for Canadian generic semaglutide products equivalent to Ozempic. The dose may then be raised to 0.5 mg once weekly. This may be followed by further increases to 1 mg and then 2 mg when additional glycemic control is needed and the prescriber recommends an increase. The exact product monograph and prescription should always take priority.

The answer depends on which semaglutide product is being used. Canada now has Sevmia – a generic version of Wegovy authorized for chronic weight management. Its labeled adult schedule starts at 0.25 mg once weekly and increases every four weeks through 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg. Generic Ozempic dosing may differ and is not intended for weight loss use.

The 0.25 mg dose is an initiation dose rather than the usual maintenance dose for weight management. Some patients may notice changes in appetite or weight while taking it. However, these changes do not automatically mean the dose should be increased. The prescriber should determine when escalation is appropriate.

The dose is generally increased from 0.25 mg to 0.5 mg after four weeks for the standard Canadian generic semaglutide schedule across different manufacturers. A healthcare professional may delay an increase when a patient is not tolerating the current dose.

The maximum recommended dose is 2 mg once weekly for the Canadian generic semaglutide equivalent to Ozempic (according to the monograph). This maximum applies to the Ozempic-equivalent product and is considered the maximum recommended dose for glycemic control. It should not be used as a general maximum for every semaglutide medication. Other semaglutide products have different indications and dosing schedules.

The maximum depends on the specific product and country. The Canadian generic Wegovy-equivalent Sevmia uses a recommended maintenance dose of 2.4 mg once weekly and does not instruct patients to increase beyond 2.4 mg. The current Wegovy label for the U.S. permits a 7.2 mg weekly dose for selected adults after dose escalation. The U.S. 7.2 mg dose should not be applied to Canadian Ozempic-equivalent or Sevmia products.

Some patients may remain on a lower dose when their prescriber determines that it is appropriate. The correct maintenance dose depends on the specific semaglutide product and its authorized indication. It also depends on the patient’s response and how well the medication is tolerated. Reaching the highest available dose is not automatically the goal of treatment.

No. Patients should not increase semaglutide earlier than directed by their healthcare provider. The escalation schedules are designed to allow the body time to adjust to treatment. Increasing the dose early can increase the likelihood of adverse effects – particularly gastrointestinal symptoms. A lack of weight loss during an individual week does not by itself mean that the dose should be increased.

A Canadian generic semaglutide product authorized as an Ozempic equivalent follows the applicable Ozempic-equivalent dosing information. The current Canadian Ozempic schedule starts at 0.25 mg once weekly, followed by 0.5 mg, with possible increases to 1 mg and 2 mg when additional glycemic control is needed. Patients should still check the monograph for their exact manufacturer and product.

Not necessarily. Canada now has a generic Wegovy-equivalent product called “Sevmia.” However, it is a separate generic product with a weight-management indication and its own product monograph. The recommended schedule begins at 0.25 mg and progresses to 0.5 mg and then 1 mg. It also has possible escalations to 1.7 mg and 2.4 mg strengths. This is different from the Canadian Ozempic-equivalent generic schedule – which has a maximum recommended dose of 2 mg weekly.

No. A compounded preparation is not an approved generic drug and may use different concentrations and delivery systems. This is particularly important when a syringe is marked in units rather than milligrams. Patients should use only the concentration and measurement instructions supplied for their specific prescription.

There is no universal number of syringe units that equals 0.25 mg of semaglutide. The conversion depends on the concentration of the particular preparation and the measuring device being used. Patients must use the pharmacy’s instructions and should not use a units-based chart from another clinic or website to calculate their dose.

A missed dose should be administered as soon as possible within five days of the scheduled dose for the Canadian Ozempic product. If more than five days have passed since the scheduled dose, the patient should skip it and resume dosing on the next scheduled day. Patients using another semaglutide product should follow that product’s own label and prescription instructions.

No. The injectable semaglutide products discussed in this article are administered once weekly – not daily. Patients should follow the prescribed weekly schedule and should never take additional doses to make up for a missed dose unless specifically instructed by a healthcare professional.

Conclusion

The dosing for generic semaglutide injections usually begins at 0.25 mg once weekly. The first Canada-authorized generic follows an Ozempic-type schedule for type 2 diabetes. This specific generic semaglutide version does not have a separate approved generic weight-loss dosage chart since the medication is not approved to be used for weight management purposes. However, Wegovy – and its generic equivalent “Sevmia” – has a distinct weight-management schedule. Dose escalation should occur only under professional direction and doses should never be increased by the patient alone to increase weight loss results. Semaglutide prescribing requires assessment of diabetes status, obesity indication (if applicable), and concurrent medications (especially insulin/sulfonylureas) prior to dose prescription. It also requires assessment of pregnancy status and relevant contraindications before selecting a dose. Never rely on universal units or pen-click conversions. The exact prescription and supplied product instructions take priority over a general chart.

Order generic semaglutide and other affordable weight loss medications from Duty Free Meds.

Sources
Canada approves first generic semaglutide for weight loss. (2026, June 29). Health Canada. https://www.canada.ca/en/health-canada/news/2026/06/canada-approves-first-generic-semaglutide-for-weight-loss.html
Canada becomes the first G7 country to approve a generic version of semaglutide. (2026, April 28). Canada.ca. https://www.canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html
Canada approves second generic semaglutide, the first G7 country to do so. (2026, May 1). Canada.ca. https://www.canada.ca/en/health-canada/news/2026/05/canada-approves-second-generic-semaglutide-the-first-g7-country-to-do-so.html
How to Use Ozempic® Pen. (n.d.). Ozempic®. https://www.ozempic.com/ozempic-pen/dosing.html
Ozempic® Pen Side Effects. (n.d.). Ozempic®. https://www.ozempic.com/ozempic-pen/side-effects.html
Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes. (n.d.). Ozempic. https://www.ozempic.com/
Ozempic® (semaglutide) injection 0.5 mg, 1 mg, 2 mg List Price & Insurance Coverage Explained. (n.d.). NovoCare®. https://www.novocare.com/diabetes/products/ozempic/explaining-list-price.html
Product Monograph. (April 28, 2026). Drug and Health Product Register. https://pdf.hres.ca/dpd_pm/00084444.PDF
Product Monograph. (May 1, 2026). Drug and Health Product Register. https://pdf.hres.ca/dpd_pm/00084514.PDF
Sissons, B. (2025, April 9). Is Compounded Semaglutide the Same as Ozempic? Healthline. https://www.healthline.com/health/drugs/compounded-semaglutide-vs-ozempic

Disclaimer: The information presented here is intended solely for educational purposes and should not be interpreted as medical advice, a diagnosis, or specific treatment recommendations. It does not imply endorsement of any particular medication or therapy. Health conditions and treatment responses can differ significantly between individuals; thus, this information is not a guarantee of safety, suitability, or effectiveness for anyone in particular. Always seek the guidance of a healthcare professional for personalized medical advice and consult them before making any health or treatment decisions.

Related Articles
November 11, 2025
13 min read
How much is Mounjaro without insurance in 2025? Learn about retail prices, savings options, discount…
September 8, 2025
12 min read
Can diabetics eat angel food cake? Discover its nutrition, GI impact, and tips for portion…
August 7, 2025
15 min read
Ozempic is a medicine prescribed to help adults with type 2 diabetes. The main ingredient…
Customer Reviews